Home >> Financial Profiles  >>  Financial Overview  
     
Financial Overview   
Financial Reports  
Half Yearly Report  

 
 
Chairman's Message in AGM  

 

 

 

General Information
Last Updated on 12/09/2007

CORPORATE HISTORY :

  •  
  • Year of Establishment (Initially as a Partnership) : 1958
  •  
  • Incorporated as a Private Limited Company : 1964
  •  
  • Technical Collaboration Agreement with Janssen Pharmaceuticals of Belgium
    (A subsidiary of Johnson & Johnson International Ltd.)
    : 1975
  •  
  • Technical Collaboration Agreement with F.Hoffman-La Roche & Co. Ltd. : 1984
  •  
  • Converted into Public Limited Company : 1991
  •  
  • Initially Public Offering (IPO) : 1994
  •  
  • Stock Exchange Listing (Dhaka & Chittagong) : 1995
  •  
  • Agreement with M/s. Bovis Tanvec Ltd. of UK for implementation of Dhaka Plant : 1996
  •  
  • Awarded ISO-9001 Cerificate : 1998
  •  
  • Awarded UK-MHRA Certificate : 2007
  •  
  • Business Lines : Manufacturing and Marketing of Pharmaceutical Finished Products, Basic Chemicals, AgroVet Products and Pesticide Products
  •  
  • Authorized Capital : US$ 16.99 Million
    (Tk. 1,000 Million)
  •  
  • Paid-up Capital : (Tk. 596.16 Million)
  •  
  • Number of Employees : 3,001
  •  
  • Subsidiary Company : Square Spinnings Ltd.
    Square Cephalosporins Ltd.
  •  
  • Associate Company : Square Textiles Ltd.
    Squar Knit Fabrics Ltd.
    Square Fashions Ltd.
    Square Hospitals Ltd.

     

    CORPORATE OPERATIONAL RESULT
    Figure in thousand : BDT
      2006-07 2005-06 2004-05

    2003-04

    2002-03
    Turnover (Gross) 8,711,035 7,085,553 6,199,135 5,482,088 5,482,088
    Value Added Tax 1,210,223 995,648 867,088 760,536 663,892
    Turnover (Net) 7,500,811 6,089,905 5,332,047 4,721,552 4,065,851
    Gross Profit 3,232,364 2,564,503 2,172,593 1,906,592 1,466,282
    Net Profit before Tax 1,722,906 1,533,043 1,513,019 1,151,636 929,604
    Net Profit after Tax 1,303,243 1,165,865 1,255,848 970,044 764,885
    Shareholders Equity 7,333,258 6,402,015 5,568,790 4,590,142 3,851,098
    Total Assets 10,486,940 9,298,987 7,907,933 6,021,497 5,164,320
    Total Bank Borrowings 2,536,524 2,334,925 1,902,331 988,611 1,070,163
    Total Current Assets 3,682,511 4,031,685 3,242,502 2,016,056 1,441,552
    Total Current Liabilities 2,555,566 2,260,755 1,949,949 1,250,676 1,247,967
    Current Ratio 1.44 1.78 1.66 1.62 1.16

    Figure in thousand : US$
      2005-06 2004-05

    2003-04

    2002-03 2001-02
    Turnover (Gross) 100790 93997.49
    93137.75 81659.93 73947.68
    Value Added Tax 14162.85 13147.65
    12921.10 11462.22 9839.91
    Turnover (Net) 86627.38 80849.84
    80216.65 70197.70 64107.77
    Gross Profit 36479.41 32943.03
    32391.98 25315.64 25072.56
    Net Profit before Tax 21807.15 22941.91
    19565.68 16049.79 15817.95
    Net Profit after Tax 16584.13 19042.42
    16480.53 13205.89 13263.15
    Shareholders Equity 91067.06 84439.57
    77984.06 66489.95 57172.79
    Total Assets 132275.77 119908.00
    102302.02
    89162.98 79044.97
    Total Bank Borrowings 33213.72 28845.04
    16795.97 18476.57 19190.95
    Total Current Assets 57349.72 49166.06
    34251.71 24888.67 25366.64
    Total Current Liabilities 32158.67 29567.08
    21248.31 21546.39 20633.48
    Current Ratio 1.78 1.66 1.62 1.16 1.23

      2006-07 2005-06 2004-05

    2003-04

    2002-03
    No. of Share Outstanding 5,961,600 4,968,000 4,320,000 3600,000 3000,000
    Dividend per Share(Cash) 50 75 77 70 70
    Dividend per Share(Stock) 50% 20% 15% 20% 20%
    Shareholders' Equity per Share 1,230 1,289 1,289 1,063 891
    Earning per Share (SPL) 218.61 234.67 290.91 224.55 177.06
    Earning per Share (Consolidated) 244.60 272.65 303.55 233.29 171.26
    Quoted Price per Share - DSE 2,447 2,276 3,768 2,272 1,178
    Quoted Price per Share - CSE 2,462 2,289 3,766 2,316 1,180
    Price Earning Ratio - DSE (Time) 11.19 9.70 12.95 10.12 6.65
    Number of Shareholders 13,009 13,206 10,486 9,270 9,295
         
    Human Resources : 2006-07 2005-06 2004-05 2003-04 2002-03
    Executive 1,242 1,143 949 895 846
    Staff 913 796 740 686 618
    Workers 846 764 705 661 656